BSE filing, NSE: ADIRASA. Summary written from the filing by ALFA Finder's alert engine.
Genpharmasec Ltd: key numbers
- Share price
- ₹1.04
- Market cap
- ₹57.59 Cr
- Revenue (annual)
- ₹139.9 Cr
- Net profit (annual)
- ₹1.60 Cr
- P/E (TTM)
- -472.7×Sector 47.2×
- Promoter holding
- 32.06%+2.08% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Genpharmasec Ltd
All →Genpharmasec Management Change
Genpharmasec's Company Secretary and Compliance Officer Hardik Makwana resigned, effective 16 November 2026. The resignation reflects a senior key managerial personnel departure, citing other professional opportunities.
Genpharmasec Financial Results
Genpharmasec approved unaudited half-year results and planned sale of its wholly owned subsidiary Clinigenome India. Company Secretary Hardik Makwana resigns effective 16 November 2026.
Genpharmasec Board Meeting Date
Genpharmasec Ltd will hold a Board meeting on 03 Nov 2026. Agenda includes proposing approval of Q2/H1 FY27 unaudited results.
Genpharmasec Other Announcement
Genpharmasec Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing provides a standard breakdown of promoter and public shareholding.
Genpharmasec Annual General Meeting
Genpharmasec Limited conducted its 34th Annual General Meeting on September 29, 2026. Shareholders considered resolutions including the adoption of FY26 financial statements and director re-appointments.
Genpharmasec Annual Report
Genpharmasec Ltd filed its 34th Annual Report for FY 2025-26 with BSE, including the AGM notice for 29 September 2026. The report covers audited financials, board updates, and governance disclosures.
Other financial results announcements
All →Deep Health AI India Q2 FY27 Results: Net Profit ₹0.2 Cr, Down 92.0% YoY
Deep Health AI India Ltd reported revenue from operations of ₹0.5 Cr (-85.3% YoY) and net profit of ₹0.2 Cr (-92.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.2 Cr · -92.0% YoY
Consecutive Commodities Q2 FY27 Results: Net Profit ₹1.7 Cr, Up 88.9% YoY
Consecutive Commodities Ltd reported revenue from operations of ₹41.6 Cr (+111.2% YoY) and net profit of ₹1.7 Cr (+88.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.7 Cr · +88.9% YoY
Shanti Gold International Q2 FY27 Results: Net Profit ₹29.6 Cr, Up 13.8% YoY
Shanti Gold International Ltd reported revenue from operations of ₹746 Cr (+73.4% YoY) and net profit of ₹29.6 Cr (+13.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹29.6 Cr · +13.8% YoY
SNL Bearings Q2 FY27 Results: Net Profit ₹3.1 Cr, Up 6.9% YoY
SNL Bearings Ltd reported revenue from operations of ₹16.1 Cr (+8.8% YoY) and net profit of ₹3.1 Cr (+6.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹3.1 Cr · +6.9% YoY
Speciality Restaurants Q2 FY27 Results: Net Profit ₹6.8 Cr, Up 51.1% YoY
Speciality Restaurants Ltd reported revenue from operations of ₹135.8 Cr (+16.7% YoY) and net profit of ₹6.8 Cr (+51.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹6.8 Cr · +51.1% YoY
Neptune Petrochemicals H1 FY27 Results: Net Profit ₹17.9 Cr, Up 23.4% YoY
Neptune Petrochemicals Ltd reported revenue from operations of ₹432.5 Cr (+6.4% YoY) and net profit of ₹17.9 Cr (+23.4% YoY) for H1 FY27.
- Key figure
- Net profit ₹17.9 Cr · +23.4% YoY